How often is Wilson disease mistaken for schizophrenia or bipolar disorder?
More often than most doctors realise — psychiatric symptoms can be the first and only sign of Wilson disease for years, and misdiagnosis lasting a decade or more is well documented in the medical literature.
Being treated for a psychiatric illness for years before anyone considered Wilson disease is not an unusual story. It is, in fact, one of the most frequently reported diagnostic tragedies in the Wilson disease community. If this happened to you or someone you love, it reflects a genuine gap in clinical awareness — not a failure of the patient or even, in many cases, a simple failure of individual physicians. The symptoms of Wilson disease can be indistinguishable from those of schizophrenia, bipolar disorder, or major depression, particularly in the early stages when there are no obvious physical signs.
What psychiatric symptoms does Wilson disease actually cause?
Wilson disease causes copper to accumulate in the liver, brain, and other organs. When copper deposits in the basal ganglia, limbic system, and frontal lobes, the result can be a wide range of psychiatric and behavioural changes.1 These include:
- Personality change (irritability, disinhibition, emotional lability)
- Psychosis with delusions or hallucinations — sometimes indistinguishable from schizophrenia
- Mood swings that mimic bipolar disorder
- Anxiety, depression, and obsessive-compulsive symptoms
- Cognitive slowing and memory difficulties
Critically, these psychiatric features can appear years before any liver symptoms or the characteristic Kayser-Fleischer rings in the eyes become detectable.2 In some patients, psychiatric symptoms remain the dominant or only presentation for the entire diagnostic journey.
How common is misdiagnosis, and for how long does it last?
Studies consistently find that psychiatric misdiagnosis in Wilson disease is common, not rare. In a review published in General Hospital Psychiatry, Zimbrean and Schilsky found that up to 20% of Wilson disease patients have an initial psychiatric presentation, and a significant proportion receive psychiatric treatment — sometimes for years — before the correct diagnosis is reached.3 Reported delays from first symptom to correct diagnosis range from two to over ten years across multiple case series.
A 2015 report in Psychosomatics described children and adolescents with Wilson disease who accumulated years of psychiatric treatment before the metabolic cause was identified — cases where insidious behavioural change was attributed to psychosocial stressors or primary psychiatric illness rather than copper toxicity.4
The neuropsychiatric manifestations are not random. A 2021 study correlating MRI changes with symptom type found that psychiatric symptoms in Wilson disease are associated with specific patterns of basal ganglia and cortical involvement, which sometimes helps distinguish Wilson disease from primary psychiatric illness — but only if an MRI is ordered and read with Wilson disease in mind.5
Why does misdiagnosis happen so persistently?
Several factors converge to make this diagnostic error common:
Wilson disease is rare. With a prevalence of approximately 1 in 30,000 people, it is not the first thing most psychiatrists or even neurologists think to rule out when a young person presents with psychosis or mood instability.6
Psychiatric symptoms often precede physical signs. If the liver is not yet visibly affected and Kayser-Fleischer rings are not yet present — which happens frequently in the early neuropsychiatric stage — there may be nothing obviously “medical” to prompt further workup.
Antipsychotic medications can partially mask symptoms. Some patients on antipsychotics experience temporary improvement in psychosis while copper continues to accumulate, delaying the realisation that the treatment is not reaching the cause.
Awareness gaps in psychiatry training. Wilson disease receives minimal coverage in standard psychiatric training curricula, meaning the majority of psychiatrists do not routinely screen for it.
What should trigger testing in a psychiatric patient?
International guidelines recommend that Wilson disease should be actively excluded in any young person (typically under 40–50 years old) presenting with new-onset psychiatric symptoms, particularly when:7
- There is no family history of psychiatric illness
- Symptoms began in childhood or early adulthood
- There are accompanying movement abnormalities (tremor, dysarthria, clumsiness), even subtle ones
- Standard psychiatric treatments are not working as expected
- Liver enzyme tests are unexpectedly abnormal
The diagnostic workup is not burdensome: serum ceruloplasmin, 24-hour urine copper, and a slit-lamp eye examination for Kayser-Fleischer rings are the first steps. A normal ceruloplasmin does not rule Wilson disease out — it must be interpreted alongside the other tests. For full details on what diagnosis involves, see how is it diagnosed.
What happens to psychiatric symptoms with proper treatment?
For many patients, psychiatric symptoms improve substantially once effective copper-lowering treatment is started.8 Improvement in mood, personality, and cognitive function has been documented in multiple cohorts following chelation therapy or zinc treatment. However, improvement is not guaranteed, and patients who have had prolonged untreated disease may have some residual neuropsychiatric effects.
This is one reason why early diagnosis matters so much — the earlier copper accumulation is arrested, the better the chance of full neuropsychiatric recovery. See also depression and anxiety for more on how Wilson disease affects mental health after diagnosis.
If this happened to you: what now?
If you spent years being treated for schizophrenia or bipolar disorder before Wilson disease was diagnosed, a few things are worth knowing:
- The psychiatric symptoms were real — they were caused by real copper toxicity in your brain.
- With proper treatment, many of those symptoms may improve or resolve.
- Any psychiatric medications you were started on should be reviewed with your Wilson disease specialist and, where appropriate, a psychiatrist who understands metabolic disease — the two disciplines need to work together.
- You are not unusual. Advocating for earlier screening — whether by sharing your story or connecting with patient organisations — genuinely helps other families avoid the same delay.
This post is patient education, not medical advice. If you or someone close to you has a new psychiatric presentation that has not responded to treatment, or if there is any concern that a medical cause has been missed, please raise this with your physician and request a formal evaluation for organic causes including Wilson disease.
References
-
Kalita, Jayantee, Vijay Kumar, Vasudev Parashar, and Usha K. Misra. “Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.” Molecular Neurobiology 58, no. 11 (2021): 6020–6031. https://doi.org/10.1007/s12035-021-02525-4. ↩
-
Czlonkowska, Anna, et al. “Wilson Disease.” Nature Reviews Disease Primers 4 (2018): 22. https://doi.org/10.1038/s41572-018-0024-5. ↩
-
Zimbrean, Paula C., and Michael L. Schilsky. “Psychiatric Aspects of Wilson Disease: A Review.” General Hospital Psychiatry 36, no. 1 (2014): 53–62. https://doi.org/10.1016/j.genhosppsych.2013.08.007. ↩
-
Millard, Hun, Paula Zimbrean, and Andrés Martin. “Delay in Diagnosis of Wilson Disease in Children With Insidious Psychiatric Symptoms: A Case Report and Review of the Literature.” Psychosomatics 56, no. 6 (2015): 700–705. https://doi.org/10.1016/j.psym.2015.07.008. ↩
-
Kalita, Jayantee, Vijay Kumar, Vasudev Parashar, and Usha K. Misra. “Neuropsychiatric Manifestations of Wilson Disease: Correlation with MRI and Glutamate Excitotoxicity.” Molecular Neurobiology 58, no. 11 (2021): 6020–6031. https://doi.org/10.1007/s12035-021-02525-4. ↩
-
Alkhouri, Naim, Regino P. Gonzalez-Peralta, and Valentina Medici. “Wilson Disease: A Summary of the Updated AASLD Practice Guidance.” Hepatology Communications 7, no. 6 (2023). https://doi.org/10.1097/HC9.0000000000000150. ↩
-
Schilsky, Michael L., Eve A. Roberts, Jeff M. Bronstein, Anil Dhawan, James P. Hamilton, Anne Marie Rivard, Mary Kay Washington, Karl Heinz Weiss, and Paula C. Zimbrean. “A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.” Hepatology 82, no. 3 (2025): E41–E90. https://doi.org/10.1002/hep.32801. ↩
-
Zimbrean, Paula C. “Psychiatric Symptoms in WD.” In Wilson Disease, edited by M. L. Schilsky, 159–170. Academic Press, 2019. https://doi.org/10.1016/B978-0-12-811077-5.00014-1. ↩
-
European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: Wilson’s Disease.” Journal of Hepatology 56, no. 3 (2012): 671–685. https://doi.org/10.1016/j.jhep.2011.11.007. ↩
यह मरीज़ शिक्षा है, न कि चिकित्सा सलाह। अपनी देखभाल से जुड़े किसी भी निर्णय के लिए हमेशा अपनी डॉक्टर टीम से बात करें।